Literature DB >> 19754408

Renoprotective potency of heme oxygenase-1 induction in rat renal ischemia-reperfusion.

Mohammed Koussai Chok1, Sophie Ferlicot, Marc Conti, Abdelhamid Almolki, Antoine Dürrbach, Sylvain Loric, Gérard Benoît, Stéphane Droupy, Pascal Eschwège.   

Abstract

PURPOSE: Renal injury caused by ischemia-reperfusion (IR) can lead to acute renal failure or delayed graft function. Renal ischemia-reperfusion (RIR) induces inflammatory disorders via activation of arachidonic acid metabolism into prostaglandin E(2) (PGE(2)). Two inducible enzymes, COX-2 and microsomal prostaglandin E synthase (mPGES), regulate PGE(2) production. Heme oxygenase-1 (HO-1) is a cytoprotective enzyme activated during cellular stress. Overexpression of HO-1 is beneficial in transplantation models including antigen-independent IR injury, acute and chronic allograft rejection.
MATERIALS AND METHODS: We investigated the effect of HO-1 induction on the COX pathway, antioxidant enzyme activities, malondialdehyde (MDA) levels, and apoptosis in rat kidneys subjected to 45 min ischemia and 1 h or 24 h reperfusion. Rats were injected intraperitoneally with either: 50 mg/kg hemin (HO-1 inducer groups: H1, H2); 50 micromol/kg ZnPP (HO-1 inhibitor groups: Hz1, Hz2); or 0.9% saline (control groups: r1, r2). Sham animals (Sh) did not undergo RIR.
RESULTS: Serum creatinine increased significantly after RIR (r vs Sh; p <0.05). Hemin treatment induced a significant decrease in serum creatinine after RIR (H vs r; p <0.05) whereas ZnPP treatment significantly increased serum creatinine levels (Sh vs Hz; p <0.05). Hemin reduced the severity of acute tubular necrosis and significantly reduced COX-2 and mPGES expression (p <0.05). Hemin did not alter depleted antioxidant enzyme activity but did decrease levels of MDA (p <0.05). Hemin also reduced caspase-3 expression.
CONCLUSIONS: HO-1 decreased the degree and severity of tubular damage after IR, probably by attenuating the cytotoxic effects of inflammatory infiltrates and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754408     DOI: 10.2174/187152809789352186

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  17 in total

1.  Systemic hemin therapy attenuates blood-brain barrier disruption after intracerebral hemorrhage.

Authors:  Xiangping Lu; Jing Chen-Roetling; Raymond F Regan
Journal:  Neurobiol Dis       Date:  2014-06-18       Impact factor: 5.996

Review 2.  Cellular pathophysiology of ischemic acute kidney injury.

Authors:  Joseph V Bonventre; Li Yang
Journal:  J Clin Invest       Date:  2011-11-01       Impact factor: 14.808

3.  BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1.

Authors:  Sheng-Hua Wu; Xiao-Qing Chen; Jing Lü; Ming-Jie Wang
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

4.  Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal.

Authors:  Sebastiaan Wesseling; Joost O Fledderus; Marianne C Verhaar; Jaap A Joles
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

5.  Transcriptome analysis of renal ischemia/reperfusion injury and its modulation by ischemic pre-conditioning or hemin treatment.

Authors:  Matheus Correa-Costa; Hátylas Azevedo; Mariane Tami Amano; Giselle Martins Gonçalves; Meire Ioshie Hyane; Marcos Antonio Cenedeze; Paulo Guilherme Renesto; Alvaro Pacheco-Silva; Carlos Alberto Moreira-Filho; Niels Olsen Saraiva Câmara
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

6.  Allicin protects against renal ischemia-reperfusion injury by attenuating oxidative stress and apoptosis.

Authors:  Maolin Li; Jinzhuo Ning; Houbao Huang; Shuchuan Jiang; Dong Zhuo
Journal:  Int Urol Nephrol       Date:  2021-11-25       Impact factor: 2.266

Review 7.  Role of heme in cardiovascular physiology and disease.

Authors:  Konrad Teodor Sawicki; Hsiang-Chun Chang; Hossein Ardehali
Journal:  J Am Heart Assoc       Date:  2015-01-05       Impact factor: 5.501

8.  Targeting HO-1 by Epigallocatechin-3-Gallate Reduces Contrast-Induced Renal Injury via Anti-Oxidative Stress and Anti-Inflammation Pathways.

Authors:  Zhao Gao; Yu Han; Yunhui Hu; Xiaoyan Wu; Yongbin Wang; Xiaoqun Zhang; Jinjuan Fu; Xue Zou; Jun Zhang; Xiongwen Chen; Pedro A Jose; Xi Lu; Chunyu Zeng
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

9.  Chronic Arachidonic Acid Administration Decreases Docosahexaenoic Acid- and Eicosapentaenoic Acid-Derived Metabolites in Kidneys of Aged Rats.

Authors:  Masanori Katakura; Michio Hashimoto; Takayuki Inoue; Abdullah Al Mamun; Yoko Tanabe; Makoto Arita; Osamu Shido
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

10.  The use of functional chemical-protein associations to identify multi-pathway renoprotectants.

Authors:  Jia Xu; Kexin Meng; Rui Zhang; He Yang; Chang Liao; Wenliang Zhu; Jundong Jiao
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.